$ELTP Recent Headlines Former CEO of Elite

New Post Public Reply Private Reply Replies (0) Message Board

Apr 28, 2014 at 10:35 AM

$ELTP Recent Headlines

Former CEO of Elite Pharmaceuticals sells all shares 10:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 4:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 5:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 12:07 p.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 1:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 2:27 p.m. Aug. 8, 2003 - Chris Kraeuter

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 9:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 9:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 11:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 1:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 12:01 a.m. May 10, 2013 - InvestorPlace.com
Racket of Their Own 12:01 a.m. Aug. 15, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 12:01 a.m. Sept. 4, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 6:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 1:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 7:43 a.m. April 22, 2014 - GlobeNewswire
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:08 a.m. April 16, 2014 - ACCESSWIRE
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:03 a.m. April 16, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:02 a.m. April 15, 2014 - ACCESSWIRE
Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs 12:16 p.m. March 27, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine 8:05 a.m. March 24, 2014 - GlobeNewswire
Applied Materials Named a 2014 World's Most Ethical Company; KeyCorp Reported 2014 Company Run Stress Test Results and Process 12:29 a.m. March 21, 2014 - ACCESSWIRE
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally 7:47 a.m. March 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 8:31 a.m. March 5, 2014 - GlobeNewswire
BlackBerry May Power Ford's Future Generation Cars 5:48 a.m. Feb. 25, 2014 - ACCESSWIRE
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201 8:01 a.m. Feb. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014 10:50 a.m. Feb. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014 4:27 p.m. Feb. 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
TrendingWallStreet.com Releases Updates on RFMD, EZPW, GFOX, and ELTP 1:17 a.m. Jan. 30, 2014 - ACCESSWIRE
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product 2:22 p.m. Jan. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 1:50 p.m. Dec. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note 8:00 a.m. Nov. 26, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 5:23 p.m. Nov. 14, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rise Treatment Center Launches in Vegas for Teens

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Unicycive's Legal Turmoil: Opportunity for Investor Action

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Brands Must Choose: Cost or Value Leadership?

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

CATL Opens Europe's Largest Battery Service Hub

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Lincoln Educational Services Faces Securities Fraud Suit

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

NORD Honors Innovators Shaping Rare Disease Treatment

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Starr Conspiracy Unveils AI Tool for B2B Tech Firms

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

illycaffè's B Corp™ Recertification Reflects Bold Commitment

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Microplastics Webinar: Navigating Complex Regulations

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...